Novel protocol for multiple-dose oral administration of the L-type Ca2+ channel blocker isradipine in mice: A dose-finding pharmacokinetic study
ABSTRACTStudies in genetically modified animals and human genetics have recently provided new insight into the role of voltage-gated L-type Ca2+ channels in human disease. Therefore, the inhibition of L-type Ca2+ channels in vivo in wildtype and mutant mice by potent dihydropyridine (DHP) Ca2+ chann...
Saved in:
Main Authors: | Tamara Theiner (Author), Nadine J. Ortner (Author), Herbert Oberacher (Author), Gospava Stojanovic (Author), Petronel Tuluc (Author), Jörg Striessnig (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Formulation and Characterization of Isradipine as Oral Nanoemulsion
by: Noor A. sadoon, et al.
Published: (2020) -
Formulation and Characterization of Isradipine Nanoparticle for Dissolution Enhancement
by: Rawaa M. Hussien, et al.
Published: (2021) -
Case report on low dose of Cilnidipine: A fourth-generation calcium channel blocker-induced gingival overgrowth
by: Sameera Gopinath, et al.
Published: (2019) -
The experience of using ACE inhibitors and Ca channel blockers in the treatment of hypertension in patients with renal cell carcinoma
by: Serhii Pasichnyk, et al.
Published: (2022) -
Selectivity of Ca2+ channel blockers for dilator actions on the isolated lower esophageal sphincter and aorta from rats
by: Akira Takahara, et al.
Published: (2018)